DVAX vs MOS · rev $277.2M vs P/E 161, rev $5.82B
Dynavax Technologies Corporation (DVAX) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
Latest reported MOS revenue for 2026-06-30 was $5.82B. Net income was -$530.4M. Revenue was up 94.2% from 2026-03-31 to 2026-06-30. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
DVAX currently screens at market cap $1.82B. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the DVAX and MOS stock pages for the full models.
Not investment advice.